Share on StockTwits

Zoetis Inc (NYSE:ZTS) issued an update on its FY14 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.50-1.54 for the period, compared to the Thomson Reuters consensus estimate of $1.53, Analyst Ratings Network reports. The company issued revenue guidance of $4.675-4.75 billion, compared to the consensus revenue estimate of $4.72 billion.

Zoetis Inc (NYSE:ZTS) opened at 32.60 on Tuesday. Zoetis Inc has a one year low of $28.14 and a one year high of $33.35. The stock has a 50-day moving average of $32.64 and a 200-day moving average of $30.86. The company has a market cap of $16.333 billion and a price-to-earnings ratio of 32.02.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.38 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.38. The company had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.16 billion. During the same quarter last year, the company posted $0.36 earnings per share. Zoetis’s revenue was up 3.9% compared to the same quarter last year. Analysts expect that Zoetis Inc will post $1.54 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 2nd. Shareholders of record on Wednesday, August 20th will be given a dividend of $0.072 per share. This represents a $0.29 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date of this dividend is Monday, August 18th.

A number of analysts have recently weighed in on ZTS shares. Analysts at Jefferies Group reiterated a buy rating on shares of Zoetis in a research note on Monday, July 14th. They now have a $38.00 price target on the stock, up previously from $37.00. On a related note, analysts at Zacks upgraded shares of Zoetis from an underperform rating to a neutral rating in a research note on Wednesday, June 4th. They now have a $33.00 price target on the stock. Finally, analysts at Morgan Stanley downgraded shares of Zoetis from an equal weight rating to an underweight rating in a research note on Wednesday, May 7th. They now have a $4.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. The company presently has an average rating of Hold and an average target price of $29.40.

Zoetis Inc, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.